![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
2026-05-13
R6H4肽(RRRRRRHHHH)修饰脂质体:实现酸性环境触发的靶向药物递送
2026-05-13
多臂pH敏感肽H7K(R2)2修饰的pH 敏感脂质体用于提高肿瘤部位药物积聚与治疗效果
2026-05-13
多功能免疫脂质体:集成TAT介导的穿膜、2C5介导的靶向与pH触发释药以增强多柔比星疗效
2026-05-13
靶向整合素 αvβ3 的小分子肽 RGD赋能的 pH 敏感脂质体递送多西他赛实现肿瘤部位高效药物释放
2026-05-13
pH敏感脂质体纳米颗粒同步包封喜树碱与siRNA用于化疗-基因联合治疗
2026-05-12
克服传统联用局限:共载帕布昔利布与氟维司群的阳离子脂质体用于乳腺癌治疗